Focused on the research and development and production of resin materials and resin end products - Hebei Lijiang
-
AboutHebei Lijiang Biotechnology Co., Ltd. is a new material manufacturer specializing in the production of functional special ion exchange resins and disposable blood perfusion devices. It is a modern high-tech enterprise integrating the research and development, production, sales, and service of resin materials and resin end products. The company was established in April 2014 with a registered capital of 52 million yuan. It plans to cover an area of 267 acres and is located in the High-tech Industrial Park of Weixian County, Hebei Province—New Material Demonstration Park. The total investment is 510 million yuan. It is a council member unit of the Ion Exchange Resin Branch of the China Membrane Industry Association.
-
Product
-
BlogsThe company will focus on the high-end market, with the purpose of serving society, solidly carrying out technological innovation and product promotion, continuously improving the development and expansion of ion exchange resin products in emerging application fields, thereby promoting the upgrading and development of related industries.
-
Company AlbumThe current phase of construction has been fully completed and put into operation, featuring a comprehensive workshop with 42 production lines for functional ion exchange resins with an annual output of 16,800 tons and a production capacity of 30,000 tons, a wastewater treatment plant with an annual treatment capacity of 403,000 tons, and a workshop producing 5,000 tons of medical-grade magnesium sulfate annually. Trial production began in July 2016, with official production starting in January 2017.
Notice Regarding Our Company's Undertaking of the Weixian County Science and Technology Research and Development Project
Release Time:
2018-04-17
To promote new developments in the company's R&D capabilities, achieve breakthroughs in research and innovation, and support the industrial restructuring of Weixian County, our company utilizes the technology R&D platform to actively undertake Weixian's scientific research tasks and has signed a technology R&D contract with the Weixian Science and Technology Bureau.
Currently, our company is undertaking the second batch of scientific research tasks for Weixian County. The project is titled "Research on Highly Selective Adsorbents for Whole Blood Perfusion." Since the project's implementation in December 2017, it has received widespread attention from county leaders and various sectors of society. The project itself has made certain progress in technological innovation and performance indicators, and the overall progress is proceeding on schedule as per the contract.
The company takes scientific and technological progress as the standard and structural adjustment as the main line, creating a favorable environment for technological advancement. While rapidly developing in all aspects, the company is willing to accept supervision from all sectors of society, continuously build its corporate image, and achieve win-win outcomes through cooperation with various parties.
Keyword:
Recommended Reading
24-05-14 14:37:56
